Company / Profit Margin
Immunocore Holdings plc Profit Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-8.9%
FY2025
5-year range
-30.1% / -8.9%
FY2022-FY2025
Trend
+46.1%
vs FY2024
Sector context
#72 of 146
Health Care
What the data says
At -8.9%, Immunocore Holdings plc's profit margin ranks #72 of 146 in the Health Care sector. Profit Margin has increased for 3 consecutive years, from -30.1% in FY2022 to -8.9% in FY2025.
Based on SEC 10-K filings.
-8.9% in FY2025 with a 3-year CAGR of +21.3%.
Improved from -22.2% to -8.9% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +21.3pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#72 of 146 in Health CareTop 49% of 146This company -8.9% Sector average -796.3%
▼
+98.9% above sector average
Key checks
Key Insights
- Immunocore Holdings plc's profit margin has grown for 3 consecutive years.
- In FY2025, profit margin increased 46.1% year-over-year.
- Currently 787.4pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score 0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -8.9% | +46.1% |
| FY2024 | -16.5% | +25.7% |
| FY2023 | -22.2% | +26.4% |
| FY2022 | -30.1% | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026